000			01577 a2200433 4500
005			20250511164244.0
264		0	_c19770129
008			197701s 0 0 eng d
022			_a0305-7372
024	7		_a10.1016/s0305-7372(76)80015-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aMauer, A M
245	0	0	_aThe current status of the treatment of childhood acute lymphoblastic leukemia. _h[electronic resource]
260			_bCancer treatment reviews _cMar 1976
300			_a17-41 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcute Disease
650	0	4	_aAge Factors
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAsparaginase _xtherapeutic use
650	0	4	_aCentral Nervous System Diseases _xdrug therapy
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCytarabine _xtherapeutic use
650	0	4	_aDaunorubicin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aLeukemia, Lymphoid _xdrug therapy
650	0	4	_aMercaptopurine _xtherapeutic use
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRemission, Spontaneous
650	0	4	_aVincristine _xtherapeutic use
700	1		_aSimone, J V
773	0		_tCancer treatment reviews _gvol. 3 _gno. 1 _gp. 17-41
856	4	0	_uhttps://doi.org/10.1016/s0305-7372(76)80015-1 _zAvailable from publisher's website
999			_c1076026 _d1076026